Here’s Why Analysts Are Positive On Prestige Consumer Healthcare Inc. (PBH)

Company Overview - Prestige Consumer Healthcare Inc. (NYSE:PBH) is a New York-based provider of over-the-counter (OTC) health and personal care products, incorporated in 1996, operating through two segments: North American OTC Healthcare and International OTC Healthcare [4] Investment Potential - Prestige Consumer Healthcare Inc. is considered one of the cheap healthcare stocks to buy heading into 2026, with a consensus 1-year median price target of $80, indicating an upside of nearly 32% [1] - Analysts remain bullish on the stock, maintaining a 'Buy' rating despite a recent price target adjustment from $100 to $88 by Canaccord [2] Financial Performance - In the second-quarter results announced on November 6, the company experienced a 6.1% decline in North American segment revenues, which was offset by a 2.5% rise in international segment revenues [3] - Management indicated that sales and earnings outperformed expectations due to specific factors, including Clear Eyes supply timing and retailer order timing, which may impact third-quarter results [2][3] Strategic Focus - The company remains focused on product innovation and e-commerce strategies as part of its growth initiatives [3]